Page 2 - Sofinnova Partners News Today

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Sensorion announces the completion of a €50.5 million placement reserved for specific categories of European and American investors, through the issue of 88,594,737 new ordinary shares at a unit...

Series A funding round to advance women’s reproductive immunotherapies

CE-Ventures, the corporate venture capital platform of Crescent Enterprises,

Anne Osdoit, CEO of Moon Surgical, explains how the Maestro System may be expanding the surgical robotics pie by bringing the capability to newer markets and how surgical robotics do not have to break the bank.

Transformative surfaceome discovery technology enables a comprehensive map of the cancer cell surface to identify a multitude of novel druggable targets....

Disco Pharmaceuticals is taking to the biotech dance floor with seed funding from major players and pipeline programs in small cell lung cancer and colorectal cancer.

Invention, Investment drive next gen materials at Biofabricate convention in Paris, with Kering, Ganni some big brands participating.

/PRNewswire/ -- GlycoEra AG, a pioneering company advancing a pipeline of extracellular protein degraders for the treatment of autoimmune disorders, today...

Sofinnova Partners has added Stanford Biodesign co-founder and director Dr. Joshua Makower as an advisory venture partner.